Jundishapur Journal of Microbiology

Published by: Kowsar

Molecular Cloning and Expression of the Leishmania infantum KMP-11 Gene

Saied Soflaei 1 , Abdolhossein Dalimi 1 , * and Fatemeh Ghafarifar 1
Authors Information
1 Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IR Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2013, 6 (2); e4798
  • Published Online: March 2, 2013
  • Article Type: Research Article
  • Received: March 13, 2012
  • Revised: May 22, 2012
  • Accepted: May 27, 2012
  • DOI: 10.5812/jjm.4798

To Cite: Soflaei S, Dalimi A, Ghafarifar F. Molecular Cloning and Expression of the Leishmania infantum KMP-11 Gene, Jundishapur J Microbiol. 2013 ; 6(2):e4798. doi: 10.5812/jjm.4798.

Abstract
Copyright © 2013, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Material and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Alexander J, Satoskar AR, Russell DG. Leishmania species: models of intracellular parasitism. J Cell Sci. 1999; 112: 2993-3002[PubMed]
  • 2. Gangneux JP, Sulahian A, Garin YJ, Farinotti R, Derouin F. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrob Agents Chemother. 1996; 40(5): 1214-8[PubMed]
  • 3. Pintado V, artin-Rabadan P, Rivera ML, Moreno S, Bouza E. Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study. Medicine (Baltimore). 2001; 80(1): 54-73[DOI]
  • 4. Sundar S, More DK, Singh MK, Singh VP, Sharma S, Makharia A, et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin Infect Dis. 2000; 31(4): 1104-7[DOI][PubMed]
  • 5. Dondji B, Perez-Jimenez E, Goldsmith-Pestana K, Esteban M, McMahon-Pratt D. Heterologous prime-boost vaccination with the LACK antigen protects against murine visceral leishmaniasis. Infect Immun. 2005; 73(8): 5286-9[DOI][PubMed]
  • 6. Shaddel M, Oormazdi H, Akhlaghi L, Kazemi B, Bandehpour M. Cloning of Leishmania Major P4 Gene Yahkhteh Med J. 2008; 10(3): 201-4
  • 7. Sujata K, Soong L, Colmenares M, Gold Smith K, Mc Mahon-Pratt D. The immunologically protective P4 Antigen of leishmania amastigotes. J Biol Chem. 2000; 275: 37789-97
  • 8. Tabatabaie F, Dalimi A, Sharifi Z, Hoseini AZ. Cloning and sequencing of Leishmania major thiol-specific-antioxidant antigen (TSA) gene. Iranian J Parasitol. 2007; 2(4): 30-41
  • 9. Tabatabaie F, Ghaffarifar F, Dalimi A, Sharifi Z, Hassan Z. Enhancement of cellular and antibody immune response to Leishmania major. Biochem Cell Arch. 2008; 8(1): 35-43
  • 10. Berberich C, Machado G, Morales G, Carrillo G, Jimenez-Ruiz A, Alonso C. The expression of the Leishmania infantum KMP-11 protein is developmentally regulated and stage specific. Biochim Biophys Acta. 1998; 1442: 230-7[DOI]
  • 11. Stebeck CE, Baron GS, Beecroft RP, Pearson TW. Molecular characterization of the kinetoplastid membrane protein-11 from African trypanosomes. Mol Biochem Parasitol. 1996; 81(1): 81-8[DOI]
  • 12. Jardim A, Hanson S, Ullman B, McCubbin WD, Kay CM, Olafson RW. Cloning and structure-function analysis of the Leishmania donovani kinetoplastid membrane protein-11. Biochem J. 1995; 305: 315-20[PubMed]
  • 13. Ramirez JR, Berberich C, Jaramillo A, Alonso C, Velez IV. Molecular and antigenic characterization of the Leishmania (Viannia) panamensis kinetoplastid membrane protein-11. Mem Inst Oswaldo Cruz. 1998; 93(2): 247-54[DOI][PubMed]
  • 14. Fuertes MA, Perez JM, Soto M, Lopez MC, Alonso C. calcium-induced conformational changes in Leishmania infantum kinetoplastid membrane protein-11. J Biol Inorg Chem. 2001; 6(1): 107-17[DOI][PubMed]
  • 15. Jensen AT, Gasim S, Ismail A, Gaafar A, Kurtzhals JA, Kemp M, et al. Humoral and cellular immune responses to synthetic peptides of the Leishmania donovani kinetoplastid membrane protein-11. Scand J Immunol. 1998; 48(1): 103-9[DOI][PubMed]
  • 16. Tolson DL, Jardim A, Schnur LF, Stebeck C, Tuckey C, Beecroft RP, et al. The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation. Infect Immun. 1994; 62(11): 4893-9[PubMed]
  • 17. Basu R, Bhaumik S, Basu JM, Naskar K, De T, Roy S. Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis. J Immunol. 2005; 174(11): 7160-71[PubMed]
  • 18. Trujillo C, Ramirez R, Velez ID, Berberich C. The humoral immune response to the kinetoplastid membrane protein-11 in patients with American leishmaniasis and Chagas disease: prevalence of IgG subclasses and mapping of epitopes. Immunol Lett. 1999; 70(3): 203-9[DOI]
  • 19. Maranon C, Thomas MC, Planelles L, Lopez MC. The immunization of A2/K(b) transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T. cruzi KMP11 antigen: identification of A2-restricted epitopes. Mol Immunol. 2001; 38(4): 279-87[DOI]
  • 20. Planelles L, Thomas M, Pulgar M, Maranon C, Grabbe S, Lopez MC. Trypanosoma cruzi heat-shock protein-70 kDa,alone or fused to the parasite KMP11 antigen, induces functional maturation of murine dendritic cells. Immunol Cell Biol. 2002; 80(3): 241-7[DOI][PubMed]
  • 21. Ramirez JR, Gilchrist K, Robledo S, Sepulveda JC, Moll H, Soldati D, et al. Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB/c mice. Vaccine. 2001; 20(3-4): 455-61[DOI]
  • 22. Berberich C, Ramirez-Pineda JR, Hambrecht C, Alber G, Skeiky YA, Moll H. Dendritic cell (DC)-based protection against an intracellular pathogen is dependent upon DC-derived IL-12 and can be induced by molecularly defined antigens. J Immunol. 2003; 170(6): 3171-9[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments